JenKem presented “PEGylation Services for Drug Delivery” at CRS in the Soapbox Sessions track.

PEGylation is an established method employed to improve the pharmacokinetic/pharmacodynamic profile of drugs. JenKem Technology presents several case studies centered around PEGylation of peptides, small molecules, and ADCs. PEGylation with JenKem® PEG products improves the half-life and solubility of the drugs, and increases the drug-antibody ratio for ADCs.

Please plan to attend this informative presentation and visit our expo stand 505 for additional information on our high quality PEG products for PEGylation, custom PEG synthesis, and PEGylation services.

To learn more about the applications of JenKem® PEGs we invite you to visit our website, and consult the references for individual products on the pages below:

Founded in 2001 by experts in PEG synthesis and PEGylation, JenKem Technology specializes exclusively in the development and manufacturing of high quality polyethylene glycol (PEG) products and derivatives, and related custom synthesis and PEGylation services. JenKem Technology is ISO 9001 and ISO 13485 certified, and adheres to ICH Q7A guidelines for GMP manufacture. The production of JenKem® PEGs is back-integrated to in-house polymerization from ethylene oxide, enabling facile traceability for regulated customers. JenKem Technology caters to the PEGylation needs of the pharmaceutical, biotechnology, medical device and diagnostics, and emerging chemical specialty markets, from laboratory scale through large commercial scale.

JenKem PEGylation Presented at CRS